Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.510
-0.180 (-10.65%)
At close: Nov 20, 2024, 4:00 PM
1.440
-0.070 (-4.64%)
After-hours: Nov 20, 2024, 5:52 PM EST
Company Description
Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals.
It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products.
The company was incorporated in 2017 and is headquartered in Caulfield, Australia.
Gelteq Limited
| Country | Australia |
| Founded | 2018 |
| IPO Date | Oct 29, 2024 |
| Industry | Health Care |
| Sector | Pharmaceuticals |
| Employees | 8 |
| CEO | Nathan Givoni |
Contact Details
Address: 639-641 Glenhuntly Road Caulfield, VIC 3162 Australia | |
| Website | gelteq.com |
Stock Details
| Ticker Symbol | GELS |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| IPO Price | $4.00 |
| CIK Code | 0001920092 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Nathan Jacob Givoni | Co-Founder, Chief Executive Officer and Director |
| Simon Hayden Szewach | Co-Founder and Executive Chairman |
| Anthony W. Panther A.C.I.S., AGIA, B.E., C.A., L.L.B., LL.B | Chief Financial Officer |
| Craig J. Young | Chief Financial Officer and Company Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 15, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Oct 31, 2024 | NT 20-F | Notification of inability to timely file Form 20-F |
| Oct 30, 2024 | 6-K | Report of foreign issuer |
| Oct 28, 2024 | CERT | Certification by an exchange approving securities for listing |
| Oct 22, 2024 | 424B4 | Prospectus |
| Oct 17, 2024 | 8-A12B | Registration of securities |
| Sep 30, 2024 | EFFECT | Notice of Effectiveness |
| Sep 25, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 20, 2024 | UPLOAD | Filing |
| Sep 12, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |